Myriad RBM Revenue and Competitors
Estimated Revenue & Valuation
- Myriad RBM's estimated annual revenue is currently $41.9M per year.
- Myriad RBM's estimated revenue per employee is $193,750
- Myriad RBM's total funding is $25M.
Employee Data
- Myriad RBM has 216 Employees.
- Myriad RBM grew their employee count by -41% last year.
Myriad RBM's People
Name | Title | Email/Phone |
---|
Myriad RBM Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.5M | 16 | 45% | N/A | N/A |
#2 | $13.8M | 89 | -7% | N/A | N/A |
#3 | $18.6M | 120 | 3% | $1.8M | N/A |
#4 | $0.9M | 6 | -40% | N/A | N/A |
#5 | $4.2M | 27 | 0% | N/A | N/A |
#6 | $3.4M | 22 | 47% | N/A | N/A |
#7 | $9.6M | 62 | 29% | N/A | N/A |
#8 | $0.9M | 6 | 20% | N/A | N/A |
#9 | $1.7M | 11 | 10% | N/A | N/A |
#10 | $15.2M | 98 | -8% | N/A | N/A |
What Is Myriad RBM?
Myriad RBM, Inc. is the world's leading multiplexed immunoassay testing laboratory, providing comprehensive protein biomarker services based on its Multi-Analyte Profiling (MAP) platform. This platform provides pre-clinical and clinical researchers with reproducible and quantitative data for a few or hundreds of proteins in a cost-effective manner. All services are performed in our CLIA certified laboratory. As a guide to drug development researchers, Myriad RBM also offers strategic biomarker services that include companion diagnostics, custom assay development, co-sponsored research programs, and innovative cell culture products. Myriad RBM's biomarker testing laboratory is a wholly owned subsidiary of Myriad Genetics, Inc. (MYGN).
keywords:N/A$25M
Total Funding
216
Number of Employees
$41.9M
Revenue (est)
-41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Myriad RBM News
Myriad RBM AbaStar MDx. QIAGEN Thermo Fisher Scientific. Region Segmentation North America (United States, Canada, Mexico) South America (Brazil, Argentina,...
... While the Coronavirus Pandemic Has a Higher Impact: AbaStar MDX, Apitope International, ExonHit Therapeutics, Metabolon Inc., Myriad RBM.
Myriad RBM Proteome Sciences Thermo Fisher Scientific Athena Diagnostics Immunarray Pvt. Ltd. Quanterix Corporation Diagenic ASA
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $48.7M | 216 | 35% | N/A |
#2 | $52.3M | 216 | 24% | N/A |
#3 | $34.6M | 217 | -22% | N/A |
#4 | $59.9M | 217 | 25% | N/A |
#5 | $69.2M | 217 | 32% | N/A |